Neutrogena and Aveeno were key drivers of Johnson & Johnson’s Consumer division results in the second quarter, potentially reflecting continued strong consumer response to launches designated as ‘Rapid’ solutions or positioned with one-week results claims.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?